The stock of Hims & Hers Health Inc (NYSE:HIMS) last traded at $15.74, down -0.51% from the previous session.
HIMS stock price is now 36.23% away from the 50-day moving average and 82.92% away from the 200-day moving average. The market capitalization of the company currently stands at $3.37B.
With the price target maintained at $16, Imperial Capital recently Upgraded its rating from In-line to Outperform for Hims & Hers Health Inc (NYSE: HIMS). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $10, while ‘Imperial Capital’ rates the stock as ‘In-line’
In other news, Dudum Andrew, Chief Executive Officer sold 50,361 shares of the company’s stock on Mar 20 ’24. The stock was sold for $823,055 at an average price of $16.34. Upon completion of the transaction, the Chief Executive Officer now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 20 ’24, Chief Financial Officer Okupe Oluyemi sold 9,912 shares of the business’s stock. A total of $156,816 was realized by selling the stock at an average price of $15.82. This leaves the insider owning 168,627 shares of the company worth $2.65 million. A total of 35.26% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $5.65 and a high of $17.16. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 3.00, and a quick ratio of 2.74. The fifty day moving average price for HIMS is $11.70 and a two-hundred day moving average price translates $8.64 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for Dec, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.01, beating analysts’ expectations of -$0.02 by 0.03. This compares to -$0.05 EPS in the same period last year. The net profit margin was -2.70% and return on equity was -7.18% for HIMS. The company reported revenue of $246.62 million for the quarter, compared to $167.2 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 47.5 percent. For the current quarter, analysts expect HIMS to generate $270.5M in revenue.
